Is BRBR or NVST more profitable?

BellRing Brands has a net margin of 6.78% compared to Envista's net margin of 2.41%. Envista's return on equity of 7.11% beat BellRing Brands' return on equity. Company Net Margins Return on Equity Return on Assets BellRing Brands 6.78% -44.06% 19.42% Envista 2.41% 7.11% 3.91%

Which has stronger earnings & valuation, SOLV or NVST?

Solventum has higher revenue and earnings than Envista. Solventum is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Solventum $8.33B 1.62 $1.56B $8.16 9.54 Envista $2.72B 1.36 $47M $0.41 55.61

Is SOLV or NVST more profitable?

Solventum has a net margin of 17.33% compared to Envista's net margin of 2.41%. Solventum's return on equity of 23.51% beat Envista's return on equity. Company Net Margins Return on Equity Return on Assets Solventum 17.33% 23.51% 7.63% Envista 2.41% 7.11% 3.91%

Which has higher valuation and earnings, SNN or NVST?

Smith & Nephew SNATS has higher revenue and earnings than Envista. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Smith & Nephew SNATS $6.16B 2.07 $625M N/A N/A Envista $2.72B 1.36 $47M $0.41 55.61

Which has higher earnings and valuation, PEN or NVST?

Penumbra has higher earnings, but lower revenue than Envista. Envista is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Penumbra $1.40B 8.94 $177.69M $4.34 73.49 Envista $2.72B 1.36 $47M $0.41 55.61

Is PEN or NVST more profitable?

Penumbra has a net margin of 11.76% compared to Envista's net margin of 2.41%. Penumbra's return on equity of 10.87% beat Envista's return on equity. Company Net Margins Return on Equity Return on Assets Penumbra 11.76% 10.87% 8.45% Envista 2.41% 7.11% 3.91%

Envista (NVST) Competitors

$22.78 -0.16 (-0.70%)

As of 01:04 PM Eastern

Compare

NVST vs. XRAY, BRBR, SOLV, SNN, and PEN

Should you buy Envista stock or one of its competitors? MarketBeat compares Envista with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Envista include DENTSPLY SIRONA (XRAY), BellRing Brands (BRBR), Solventum (SOLV), Smith & Nephew SNATS (SNN), and Penumbra (PEN).

How does Envista compare to DENTSPLY SIRONA?

Envista (NYSE:NVST) and DENTSPLY SIRONA (NASDAQ:XRAY) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends.

Envista has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market.

Envista has a net margin of 2.41% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
DENTSPLY SIRONA	-17.06%	18.83%	5.13%

In the previous week, DENTSPLY SIRONA had 6 more articles in the media than Envista. MarketBeat recorded 6 mentions for DENTSPLY SIRONA and 0 mentions for Envista. Envista's average media sentiment score of 1.00 beat DENTSPLY SIRONA's score of 0.02 indicating that Envista is being referred to more favorably in the media.

Company	Overall Sentiment
Envista	Positive
DENTSPLY SIRONA	Neutral

95.7% of DENTSPLY SIRONA shares are held by institutional investors. 1.0% of Envista shares are held by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Envista currently has a consensus price target of $28.83, suggesting a potential upside of 26.46%. DENTSPLY SIRONA has a consensus price target of $13.82, suggesting a potential upside of 41.72%. Given DENTSPLY SIRONA's higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Envista has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.36	$47M	$0.41	55.61
DENTSPLY SIRONA	$3.68B	0.53	-$598M	-$3.15	N/A

Summary

Envista beats DENTSPLY SIRONA on 9 of the 16 factors compared between the two stocks.

How does Envista compare to BellRing Brands?

BellRing Brands (NYSE:BRBR) and Envista (NYSE:NVST) are related companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations and risk.

BellRing Brands has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market. Comparatively, Envista has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market.

BellRing Brands has a net margin of 6.78% compared to Envista's net margin of 2.41%. Envista's return on equity of 7.11% beat BellRing Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BellRing Brands	6.78%	-44.06%	19.42%
Envista	2.41%	7.11%	3.91%

95.0% of BellRing Brands shares are held by institutional investors. 1.5% of BellRing Brands shares are held by insiders. Comparatively, 1.0% of Envista shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, BellRing Brands had 3 more articles in the media than Envista. MarketBeat recorded 3 mentions for BellRing Brands and 0 mentions for Envista. BellRing Brands' average media sentiment score of 1.81 beat Envista's score of 1.00 indicating that BellRing Brands is being referred to more favorably in the media.

Company	Overall Sentiment
BellRing Brands	Very Positive
Envista	Positive

BellRing Brands presently has a consensus price target of $22.47, indicating a potential upside of 157.06%. Envista has a consensus price target of $28.83, indicating a potential upside of 26.46%. Given BellRing Brands' higher probable upside, equities research analysts plainly believe BellRing Brands is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BellRing Brands	2 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.37
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

BellRing Brands has higher earnings, but lower revenue than Envista. BellRing Brands is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BellRing Brands	$2.32B	0.44	$216.20M	$1.29	6.78
Envista	$2.72B	1.36	$47M	$0.41	55.61

Summary

BellRing Brands beats Envista on 10 of the 16 factors compared between the two stocks.

How does Envista compare to Solventum?

Solventum (NYSE:SOLV) and Envista (NYSE:NVST) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk.

Solventum has higher revenue and earnings than Envista. Solventum is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solventum	$8.33B	1.62	$1.56B	$8.16	9.54
Envista	$2.72B	1.36	$47M	$0.41	55.61

Solventum has a net margin of 17.33% compared to Envista's net margin of 2.41%. Solventum's return on equity of 23.51% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solventum	17.33%	23.51%	7.63%
Envista	2.41%	7.11%	3.91%

Solventum has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market. Comparatively, Envista has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market.

In the previous week, Solventum had 6 more articles in the media than Envista. MarketBeat recorded 6 mentions for Solventum and 0 mentions for Envista. Envista's average media sentiment score of 1.00 beat Solventum's score of 0.38 indicating that Envista is being referred to more favorably in the news media.

Company	Overall Sentiment
Solventum	Neutral
Envista	Positive

Solventum currently has a consensus target price of $84.25, indicating a potential upside of 8.19%. Envista has a consensus target price of $28.83, indicating a potential upside of 26.46%. Given Envista's higher possible upside, analysts plainly believe Envista is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solventum	1 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.50
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Solventum beats Envista on 10 of the 14 factors compared between the two stocks.

How does Envista compare to Smith & Nephew SNATS?

Smith & Nephew SNATS (NYSE:SNN) and Envista (NYSE:NVST) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk.

In the previous week, Smith & Nephew SNATS had 1 more articles in the media than Envista. MarketBeat recorded 1 mentions for Smith & Nephew SNATS and 0 mentions for Envista. Envista's average media sentiment score of 1.00 beat Smith & Nephew SNATS's score of 0.00 indicating that Envista is being referred to more favorably in the news media.

Company	Overall Sentiment
Smith & Nephew SNATS	Neutral
Envista	Positive

25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Comparatively, 1.0% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Smith & Nephew SNATS has a beta of 0.55, meaning that its stock price is 45% less volatile than the broader market. Comparatively, Envista has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market.

Smith & Nephew SNATS has higher revenue and earnings than Envista.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew SNATS	$6.16B	2.07	$625M	N/A	N/A
Envista	$2.72B	1.36	$47M	$0.41	55.61

Smith & Nephew SNATS currently has a consensus price target of $30.93, indicating a potential upside of 3.43%. Envista has a consensus price target of $28.83, indicating a potential upside of 26.46%. Given Envista's higher probable upside, analysts clearly believe Envista is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew SNATS	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

Envista has a net margin of 2.41% compared to Smith & Nephew SNATS's net margin of 0.00%. Envista's return on equity of 7.11% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew SNATS	N/A	N/A	N/A
Envista	2.41%	7.11%	3.91%

Summary

Smith & Nephew SNATS beats Envista on 8 of the 15 factors compared between the two stocks.

How does Envista compare to Penumbra?

Penumbra (NYSE:PEN) and Envista (NYSE:NVST) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings and dividends.

Penumbra has higher earnings, but lower revenue than Envista. Envista is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.40B	8.94	$177.69M	$4.34	73.49
Envista	$2.72B	1.36	$47M	$0.41	55.61

Penumbra presently has a consensus target price of $361.33, indicating a potential upside of 13.28%. Envista has a consensus target price of $28.83, indicating a potential upside of 26.46%. Given Envista's stronger consensus rating and higher probable upside, analysts plainly believe Envista is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

Penumbra has a net margin of 11.76% compared to Envista's net margin of 2.41%. Penumbra's return on equity of 10.87% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	11.76%	10.87%	8.45%
Envista	2.41%	7.11%	3.91%

In the previous week, Penumbra had 2 more articles in the media than Envista. MarketBeat recorded 2 mentions for Penumbra and 0 mentions for Envista. Penumbra's average media sentiment score of 1.19 beat Envista's score of 1.00 indicating that Penumbra is being referred to more favorably in the media.

Company	Overall Sentiment
Penumbra	Positive
Envista	Positive

88.9% of Penumbra shares are owned by institutional investors. 2.9% of Penumbra shares are owned by insiders. Comparatively, 1.0% of Envista shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Penumbra has a beta of 0.71, indicating that its stock price is 29% less volatile than the broader market. Comparatively, Envista has a beta of 0.88, indicating that its stock price is 12% less volatile than the broader market.

Summary

Penumbra beats Envista on 11 of the 16 factors compared between the two stocks.

Get Envista News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NVST vs. The Competition

Export

Metric	Envista	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$3.71B	$7.91B	$6.26B	$23.13B
Dividend Yield	N/A	2.56%	2.69%	4.09%
P/E Ratio	55.61	15.37	22.35	31.16
Price / Sales	1.36	5.68	555.60	14.72
Price / Cash	10.76	17.23	42.31	24.78
Price / Book	1.21	3.52	9.82	4.68
Net Income	$47M	$224.05M	$3.56B	$1.07B
7 Day Performance	-2.24%	-1.44%	-1.16%	-0.38%
1 Month Performance	-13.36%	-0.06%	3.85%	0.52%
1 Year Performance	21.76%	-0.13%	27.33%	25.86%

Envista Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NVST Envista	3.4695 of 5 stars	$22.78 -0.7%	$28.83 +26.6%	+26.6%	$3.71B	$2.72B	55.56	12,000
XRAY DENTSPLY SIRONA	4.534 of 5 stars	$10.21 flat	$13.82 +35.3%	-37.1%	$2.05B	$3.68B	N/A	14,000
BRBR BellRing Brands	4.4636 of 5 stars	$8.93 +0.2%	$22.47 +151.6%	-85.6%	$1.04B	$2.32B	6.92	380	Positive News
SOLV Solventum	3.016 of 5 stars	$76.92 +0.1%	$84.25 +9.5%	+4.5%	$13.31B	$8.33B	9.43	20,000
SNN Smith & Nephew SNATS	1.8213 of 5 stars	$30.51 -0.1%	$30.93 +1.4%	+0.8%	$13.04B	$6.16B	N/A	16,988

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NVST) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Envista (NVST) Competitors

NVST vs. XRAY, BRBR, SOLV, SNN, and PEN

How does Envista compare to DENTSPLY SIRONA?

Summary

How does Envista compare to BellRing Brands?

Summary

How does Envista compare to Solventum?

Summary

How does Envista compare to Smith & Nephew SNATS?

Summary

How does Envista compare to Penumbra?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVST vs. The Competition

Envista Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Envista (NVST) Competitors

NVST vs. XRAY, BRBR, SOLV, SNN, and PEN

How does Envista compare to DENTSPLY SIRONA?

Which has more risk & volatility, NVST or XRAY?

Is NVST or XRAY more profitable?

Does the media favor NVST or XRAY?

Do insiders and institutionals believe in NVST or XRAY?

Do analysts prefer NVST or XRAY?

Which has preferable valuation and earnings, NVST or XRAY?

Summary

How does Envista compare to BellRing Brands?

Which has more risk and volatility, BRBR or NVST?

Is BRBR or NVST more profitable?

Do institutionals and insiders believe in BRBR or NVST?

Does the media prefer BRBR or NVST?

Do analysts prefer BRBR or NVST?

Which has preferable earnings and valuation, BRBR or NVST?

Summary

How does Envista compare to Solventum?

Which has stronger earnings & valuation, SOLV or NVST?

Is SOLV or NVST more profitable?

Which has more risk & volatility, SOLV or NVST?

Does the media refer more to SOLV or NVST?

Do analysts prefer SOLV or NVST?

Summary

How does Envista compare to Smith & Nephew SNATS?

Does the media prefer SNN or NVST?

Do insiders and institutionals believe in SNN or NVST?

Which has more risk & volatility, SNN or NVST?

Which has higher valuation and earnings, SNN or NVST?

Do analysts recommend SNN or NVST?

Is SNN or NVST more profitable?

Summary

How does Envista compare to Penumbra?

Which has higher earnings and valuation, PEN or NVST?

Do analysts recommend PEN or NVST?

Is PEN or NVST more profitable?

Does the media refer more to PEN or NVST?

Do insiders & institutionals have more ownership in PEN or NVST?

Which has more volatility and risk, PEN or NVST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVST vs. The Competition

Envista Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools